HarishGAhujaMD

Oncology • Fargo, ND

Physician

Join to view full profile

Dr. Ahuja is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ahuja's full profile

Already have an account?

Office
1702 University Dr S
Fargo, ND 58103
Phone+1 715-847-2866

Education & Training

University at BuffaloFellowship, Hematology and Medical Oncology, 1997 - 1998
Grant Medical CollegeClass of 1978

Certifications & Licensure

MI State Medical License 2011 - 2027
CA State Medical License 2024 - 2026
IN State Medical License 2024 - 2025
MN State Medical License 2024 - 2025
ND State Medical License 2024 - 2025
WI State Medical License 2000 - 2025
AL State Medical License 1996 - 2000
NY State Medical License 1999 - 2000
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Join now to see all

Clinical Trials

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
Completed
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma Start of enrollment: 2015 Nov 23
Recruiting
Phase 2, Phase 3
Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations Start of enrollment: 2018 Aug 01
Recruiting
Phase 2
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) Start of enrollment: 2019 Jul 26
Active, not recruiting
Phase 3
Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker Start of enrollment: 2020 Jul 20
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

43 citations
Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer
Steven Attia, Jens C. Eickhoff, George Wilding, Douglas G. McNeel, Jules H. Blank
Clinical Cancer Research. 2008-04-15
78 citations
t(9;11)(p22;p15) in Acute Myeloid Leukemia Results in a Fusion between NUP98 and the Gene Encoding Transcriptional Coactivators p52 and p75-Lens Epithelium-derived Gro...
Harish G. Ahuja, Jianming Hong, Peter D. Aplan, Lucene Tcheurekdjian, Stephen J. Forman
Cancer Research. 2000-11-15
34 citations
A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study
Timothy S. Fenske, Namrata Shah, Kyung Mann Kim, Sandeep Saha, Chong Zhang
Cancer. 2015-10-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member